Zacks Market Edge · Zacks Investment Research
5 Large Cap Drug Stocks: Values or Traps?
October 3, 2025·35 min·3 clips
Why are large cap drug stocks like Pfizer and Merck cheap, yet still considered traps by value investors?
As heard by us
A value-screen look at whether big pharma still looks cheap.
Tracy Reineck takes a steady, value-first look at Pfizer, Merck, and AbbVie. The episode stays close to the numbers: dividend yield, earnings growth, PEG, and price to sales all get a turn, along with the same question that hangs over names like these, whether they are cheap or…
Why you'd press play
You want to know whether big pharma is value, or just a familiar trap.
Listen to the show on